Transforming
Orthopedic Care

Regenexx is redefining musculoskeletal care through interventional orthobiologics — research-based, image-guided procedures that help patients avoid invasive surgeries. Our licensed network of physicians uses patented Regenexx protocols, advanced lab processes, and proven outcomes data to deliver safer, more effective orthopedic care in their communities.

Regenexx Corporate Program Overview

Leading the Field Since 2005

Regenexx pioneered the world’s first orthopedic bone marrow concentrate (BMC) procedure in 2005. Since then, we’ve become the leader in interventional orthobiologics by:

Publishing nearly half of all global research on BMC.
Building the largest outcomes registry in the field.
Holding 24+ patents for orthobiologic protocols and processes.

Explore our history

What We Offer Physicians

Regenexx provides physicians with the tools and support to deliver customized orthobiologic solutions, including:

Platelet-Rich Plasma (PRP): Concentrates platelets from a patient’s blood to promote targeted tissue repair and healing.
Bone Marrow Concentrate (BMC): Concentrates cells from a patient’s bone marrow to provide a powerful, minimally invasive solution for orthopedic conditions.